Neurology-Genetics

Papers
(The median citation count of Neurology-Genetics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Late-onset vs nonmendelian early-onset Alzheimer disease82
Prevalence of RFC1 -mediated spinocerebellar ataxia in a North American ataxia cohort40
The SPID-GBA study36
Mitochondrial diseases in North America35
ALS in Danish Registries33
Clinical utility of multigene analysis in over 25,000 patients with neuromuscular disorders31
Mutations in the m-AAA proteases AFG3L2 and SPG7 are causing isolated dominant optic atrophy30
Practical guidelines to manage discordant situations of SMN2 copy number in patients with spinal muscular atrophy29
Genetic risk for Alzheimer disease predicts hippocampal volume through the human lifespan29
Multigene Panel Testing in a Large Cohort of Adults With Epilepsy28
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants27
Neurologic outcomes in Friedreich ataxia27
Is Focal Cortical Dysplasia/Epilepsy Caused by Somatic MTOR Mutations Always a Unilateral Disorder?26
Somatic SLC35A2 mosaicism correlates with clinical findings in epilepsy brain tissue25
Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes24
Intragenic variants in the SMN1 gene determine the clinical phenotype in 5q spinal muscular atrophy24
Hydrocephalus and diffuse choroid plexus hyperplasia in primary ciliary dyskinesia-related MCIDAS mutation24
Epilepsy Course and Developmental Trajectories in STXBP1 -DEE23
Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants22
Characterization of the phenotype with cognitive impairment and protein mislocalization in SCA3421
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy revisited21
APOE ϵ 4 modifies the relationship between infectious burden and poor cognition21
Progressive Myoclonus Epilepsies20
Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease20
SLC12A2 mutations cause NKCC1 deficiency with encephalopathy and impaired secretory epithelia20
WGS and RNA Studies Diagnose Noncoding DMD Variants in Males With High Creatine Kinase20
Neuronal intranuclear inclusion disease presenting with an MELAS-like episode in chronic polyneuropathy20
Expanding the Spectrum of Movement Disorders Associated With C9orf72 Hexanucleotide Expansions19
Expanding the phenotypic and molecular spectrum of RNA polymerase III–related leukodystrophy19
D-DEMØ, a distinct phenotype caused by ATP1A3 mutations18
Novel TUBA4A Variant Associated With Familial Frontotemporal Dementia18
Early-Onset Cerebral Amyloid Angiopathy and Alzheimer Disease Related to an APP Locus Triplication17
Polygenic Risk Scores Augment Stroke Subtyping17
Brain Regional Differences in Hexanucleotide Repeat Length in X-Linked Dystonia-Parkinsonism Using Nanopore Sequencing17
Integrative Network-Based Analysis Reveals Gene Networks and Novel Drug Repositioning Candidates for Alzheimer Disease17
Polygenic risk scores of several subtypes of epilepsies in a founder population16
Clinical and pathologic phenotype of a large family with heterozygous STUB1 mutation16
RFC1 -Related Disease16
Identification of a novel mutation in ATP13A2 associated with a complicated form of hereditary spastic paraplegia15
Progress in Amyotrophic Lateral Sclerosis Gene Discovery15
Molecular diagnosis of muscular diseases in outpatient clinics15
Detailed Clinical and Psychological Phenotype of the X-linked HNRNPH2 -Related Neurodevelopmental Disorder15
Variant repeats within the DMPK CTG expansion protect function in myotonic dystrophy type 114
Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF114
FLNC-Associated Myofibrillar Myopathy14
Heterozygous STUB1 missense variants cause ataxia, cognitive decline, and STUB1 mislocalization14
Migraine, Stroke, and Cervical Arterial Dissection14
Evidence for a Dual-Pathway, 2-Hit Genetic Model for Focal Cortical Dysplasia and Epilepsy14
PURA- Related Developmental and Epileptic Encephalopathy14
Rapid progressive ALS in a patient with a DNAJC7 loss-of-function mutation13
Delineating the phenotypic spectrum of sulfite oxidase and molybdenum cofactor deficiency13
Disease duration in autosomal dominant familial Alzheimer disease13
Diagnosing Mitochondrial Disorders Remains Challenging in the Omics Era13
A splice variant in ATAD3A expands the clinical and genetic spectrum of Harel-Yoon syndrome13
Ethnicity-related DMD Genotype Landscapes in European and Non-European Countries13
Expanding Clinical Spectrum of C9ORF72 -Related Disorders and Promising Therapeutic Strategies13
MYORG -related disease is associated with central pontine calcifications and atypical parkinsonism13
CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease12
Therapy Trial Design in Vanishing White Matter12
Integrated sequencing and array comparative genomic hybridization in familial Parkinson disease12
Mild Phenotype of Wolfram Syndrome Associated With a Common Pathogenic Variant Is Predicted by a Structural Model of Wolframin12
ALS in Finland11
Integrative analysis identifies the association between CASZ1 methylation and ischemic stroke11
C9orf72 and the Care of the Patient With ALS or FTD11
Association of blood-based transcriptional risk scores with biomarkers for Alzheimer disease11
Use of local genetic ancestry to assess TOMM40 -523′ and risk for Alzheimer disease11
LBSL11
Can Anti–β-amyloid Monoclonal Antibodies Work in Autosomal Dominant Alzheimer Disease?10
Trigeminal Neuralgia TRPM8 Mutation10
V374A KCND3 Pathogenic Variant Associated With Paroxysmal Ataxia Exacerbations10
Primary mitochondrial myopathy10
Revealing the Mutational Spectrum in Southern Africans With Amyotrophic Lateral Sclerosis10
Cerebellar ataxia, neuropathy, hearing loss, and intellectual disability due to AIFM1 mutation9
Association of a structural variant within the SQSTM1 gene with amyotrophic lateral sclerosis9
Isoform-specific loss of dystonin causes hereditary motor and sensory neuropathy9
Acute encephalopathy after head trauma in a patient with a RHOBTB2 mutation9
New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra9
SLC1A3 variant associated with hemiplegic migraine and acetazolamide-responsive MRS changes9
MAP3K6 Mutations in a Neurovascular Disease Causing Stroke, Cognitive Impairment, and Tremor9
Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 19
Amyotrophic Lateral Sclerosis Genetic Access Program9
Clinical Features and Classification of Neuronal Intranuclear Inclusion Disease9
Hereditary cerebral amyloid angiopathy, Piedmont-type mutation9
Case of Neuronal Intranuclear Inclusion Disease With Dynamic Perfusion Changes Lacking Typical Signs on Diffusion-Weighted Imaging9
Biallelic Variants in the COLGALT1 Gene Causes Severe Congenital Porencephaly9
Synonymous variants associated with Alzheimer disease in multiplex families9
Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia9
Novel dominant MPAN family with a complex genetic architecture as a basis for phenotypic variability9
Disease-modifying effects of an SCAF4 structural variant in a predominantly SOD1 ALS cohort9
Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis8
Phenotypic Spectrum of Seizure Disorders in MBD5-Associated Neurodevelopmental Disorder8
EIF2AK2 -related Neurodevelopmental Disorder With Leukoencephalopathy, Developmental Delay, and Episodic Neurologic Regression Mimics Pelizaeus-Merzbacher Disease8
Genetic Influences on Hippocampal Subfields8
Frequency and Phenotype Associations of Rare Variants in 5 Monogenic Cerebral Small Vessel Disease Genes in 200,000 UK Biobank Participants8
Gerstmann-Sträussler-Scheinker disease ( PRNP p.D202N) presenting with atypical parkinsonism8
Clinical-Genetic Features Influencing Disability in Spastic Paraplegia Type 48
NR4A2 Mutations Can Cause Intellectual Disability and Language Impairment With Persistent Dystonia-Parkinsonism7
Ketogenic diet reduces Lafora bodies in murine Lafora disease7
Congenital myasthenic syndrome caused by a frameshift insertion mutation in GFPT17
Cumulative Genetic Risk and APOE ε4 Are Independently Associated With Dementia Status in a Multiethnic, Population-Based Cohort7
Genetic Evidence for Protective Effects of Angiotensin-Converting Enzyme Against Alzheimer Disease But Not Other Neurodegenerative Diseases in European Populations7
Transcript-Specific Loss-of-Function Variants in VPS16 Are Enriched in Patients With Dystonia7
Out-of-Frame Mutations in ACTN2 Last Exon Cause a Dominant Distal Myopathy With Facial Weakness7
Dominant Distal Myopathy 3 (MPD3) Caused by a Deletion in the HNRNPA1 Gene7
COX deficiency and leukoencephalopathy due to a novel homozygous APOPT1/COA8 mutation7
Blended Phenotype of Silver-Russell Syndrome and SPG50 Caused by Maternal Isodisomy of Chromosome 77
Expanded genetic insight and clinical experience of DNMT1-complex disorder7
Genome Sequencing in the Parkinson Disease Clinic7
Genetic risk scores and hallucinations in patients with Parkinson disease7
Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2 -Associated Infantile Epilepsy7
Biallelic DAB1 Variants Are Associated With Mild Lissencephaly and Cerebellar Hypoplasia7
Effect of Body Weight on Age at Onset in Huntington Disease7
Manifesting carriers of X-linked myotubular myopathy7
Mutation in ZDHHC15 Leads to Hypotonic Cerebral Palsy, Autism, Epilepsy, and Intellectual Disability7
Heritability of cervical spinal cord structure6
Migrating Focal Seizures and Myoclonic Status in ARV1- Related Encephalopathy6
Expanding the Genotypic Spectrum of Congenital Sensory and Autonomic Neuropathies Using Whole-Exome Sequencing6
Diagnosis of Shashi-Pena Syndrome Caused by Chromosomal Rearrangement Using Nanopore Sequencing6
Who and Why? Requests for Presymptomatic Genetic Testing for Amyotrophic Lateral Sclerosis/Frontotemporal Dementia vs Huntington Disease6
Genetic background of ataxia in children younger than 5 years in Finland6
Matrix metalloproteinase-degraded type I collagen is associated with APOE/TOMM40 variants and preclinical dementia6
4H leukodystrophy6
Clinical Evidence for Variegated Silencing in Patients With Friedreich Ataxia6
New recessive mutations in SYT2 causing severe presynaptic congenital myasthenic syndromes6
Frequency of GAA- FGF14 Ataxia in a Large Cohort of Brazilian Patients With Unsolved Adult-Onset Cerebellar Ataxia6
Biallelic Pathogenic Variants in TNNT3 Associated With Congenital Myopathy6
Homozygous SOD1 Variation L144S Produces a Severe Form of Amyotrophic Lateral Sclerosis in an Iranian Family6
Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease6
Race and Alzheimer Disease Biomarkers6
Intronic pentanucleotide expansion in the replication factor 1 gene ( RFC1 ) is a major cause of adult-onset ataxia6
Whole-Genome and Long-Read Sequencing Identify a Novel Mechanism in RFC1 Resulting in CANVAS Syndrome5
Congenital immobility and stiffness related to biallelic ATAD1 variants5
Phenotypic variability in chorea-acanthocytosis associated with novel VPS13A mutations5
Herpes simplex virus 2 encephalitis in a patient heterozygous for a TLR3 mutation5
Novel truncating mutations of MYO18B causing congenital myopathy in a Swiss patient5
Biallelic LINE insertion mutation in HACD1 causing congenital myopathy5
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis5
Pathogenic NOTCH3 Variants Are Frequent Among the Korean General Population5
LAMA2 -Related Muscular Dystrophy Across the Life Span5
Ataxia-Pancytopenia Syndrome due to a de Novo SAMD9L Mutation5
Novel Mutation of the TGF-β 3 Protein (Loeys-Dietz Type 5) Associated With Aortic and Carotid Dissections5
U-Fiber Leukoencephalopathy Due to a Novel Mutation in the TACO1 Gene5
Novel Variations in the KDM5C Gene Causing X-Linked Intellectual Disability5
GLUT1 deficiency5
Prevalence of Frontotemporal Dementia in Females of 5 Hispanic Families With R159H VCP Multisystem Proteinopathy5
Neuraxial dysraphism in EPAS1- associated syndrome due to improper mesenchymal transition5
Relationships of APOE Genotypes With Small RNA and Protein Cargo of Brain Tissue Extracellular Vesicles From Patients With Late-Stage AD5
PRPS1 Gene Mutation Causes Complex X-Linked Adult-Onset Cerebellar Ataxia in Women5
Exome Sequencing and Multigene Panel Testing in 1,411 Patients With Adult-Onset Neurologic Disorders5
Effect of the RNF213 p.R4810K Variant on the Progression of Intracranial Artery Stenosis5
Highly Elevated Prevalence of Spinobulbar Muscular Atrophy in Indigenous Communities in Canada Due to a Founder Effect5
Clinical Manifestation of Nebulin-Associated Nemaline Myopathy4
Phenotype of Patients With Charcot-Marie-Tooth With the p.His123Arg Mutation in GDAP1 in Northern Finland4
Clinical Deep Phenotyping of ABCA7 Mutation Carriers4
Paroxysmal Kinesigenic Dyskinesia Caused by 16p11.2 Microdeletion and Related Clinical Features4
A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease4
Distinguishing Loss-of-Function and Gain-of-Function SCN8A Variants Using a Random Forest Classification Model Trained on Clinical Features4
POLR1C variants dysregulate splicing and cause hypomyelinating leukodystrophy4
Pathogenic DNM1 Gene Variant Presenting With Unusually Nonsevere Neurodevelopmental Phenotype: A Case Report4
Progressive Ataxia and Neurologic Regression in RFXANK -Associated Bare Lymphocyte Syndrome4
Heterozygous variants in DCC4
Neurodevelopmental regression, severe generalized dystonia, and metabolic acidosis caused by POLR3A mutations4
Cerebral arteriopathy associated with heterozygous variants in the casitas B-lineage lymphoma gene4
Expanding the phenotype of MTOR -related disorders and the Smith-Kingsmore syndrome4
Genetic testing utilization for patients with neurologic disease and the limitations of claims data4
Autosomal Dominant ANO5-Related Disorder Associated With Myopathy and Gnathodiaphyseal Dysplasia4
Possible Somatic Mosaicism of Novel FUS Variant in Familial Amyotrophic Lateral Sclerosis4
Overview of the Clinical Approach to Individuals With Cerebellar Ataxia and Neuropathy4
Cognitive Impairment in a Complex Family With AAGGG and ACAGG Repeat Expansions in RFC1 Detected by ExpansionHunter Denovo4
Adult-Onset Spinal Muscular Atrophy due to Mutations in the VRK1 Gene4
A Fast and Robust Strategy to Remove Variant-Level Artifacts in Alzheimer Disease Sequencing Project Data4
Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 14
Integrating Genetic Structural Variations and Whole-Genome Sequencing Into Clinical Neurology4
Association of HLA-DQA2 and HLA-B With Moyamoya Disease in the Chinese Han Population4
FDX2 and ISCU Gene Variations Lead to Rhabdomyolysis With Distinct Severity and Iron Regulation4
Ataxia and Parkinsonism in a Woman With a VCP Variant and Long-Normal Repeats in the SCA2 Allele4
Chromosomal Microarray Analysis in Pregnancies With Corpus Callosum or Posterior Fossa Anomalies4
Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation4
Neuropathology-Independent Association Between APOE Genotype and Cognitive Decline Rate in the Normal Aging-Early Alzheimer Continuum3
Homoplasmic mitochondrial tRNA Pro mutation causing exercise-induced muscle swelling and fatigue3
Complex 4q35 and 10q26 Rearrangements3
Three-dimensional imaging in myotonic dystrophy type 13
Occurrence of Amyotrophic Lateral Sclerosis in Type 1 Gaucher Disease3
Novel Mutation m.10372A>G in MT-ND3 Causing Sensorimotor Axonal Polyneuropathy3
Toward the Definition of Patient-Reported Outcome Measurements in Hereditary Spastic Paraplegia3
Recessive COL4A2 Mutation Leads to Intellectual Disability, Epilepsy, and Spastic Cerebral Palsy3
Novel Pathogenic Sequence Variation m.5789T>C Causes NARP Syndrome and Promotes Formation of Deletions of the Mitochondrial Genome3
Brainstem ischemic syndrome in juvenile NF23
Novel TOP3A Variant Associated With Mitochondrial Disease3
Overview of Neuromuscular Disorder Molecular Diagnostic Experience for the Population of Latvia3
DNA Methylation of the Natriuretic Peptide System Genes and Ischemic Stroke3
Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices3
KCNQ2 encephalopathy manifesting with Rett-like features3
A 3.9-Mb Deletion on 2p11.2 Comprising the REEP1 Gene Causes Early-Onset Atypical Parkinsonism3
Novel Homozygous Variant in COQ7 in Siblings With Hereditary Motor Neuropathy3
Familial Lipomas Without Classic Neurofibromatosis-1 Caused by a Missense Germline NF1 Mutation3
Genome-wide Analysis of Motor Progression in Parkinson Disease3
Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies3
Diagnostic Efficacy of Genetic Studies in a Series of Hereditary Cerebellar Ataxias in Eastern Spain3
Miglustat Therapy for SCARB2 -Associated Action Myoclonus–Renal Failure Syndrome3
Phenotypic Spectrum of DNM2 -Related Centronuclear Myopathy3
Body Mass Index and Height in the Friedreich Ataxia Clinical Outcome Measures Study3
Novel Cysteine-Sparing Hypomorphic NOTCH3 A1604T Mutation Observed in a Family With Migraine and White Matter Lesions3
Neurofibromatosis-1 Gene Mutational Profiles Differ Between Syndromic Disease and Sporadic Cancers3
Genetic Testing for Malformations of Cortical Development3
Does SCA45 Cause Very Late-Onset Pure Cerebellar Ataxia?3
Biotinidase deficiency3
0.042088031768799